Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Tolerance and the Mode of Administration of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots

NCT05203263 is registered in ClinicalTrials.gov with Cryonove Pharma as lead sponsor.

NCT NCT05203263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05203263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Tolerance and the Mode of Administration of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Brown Spots
Lead sponsor
Cryonove Pharma
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2021
Completion date
February 15, 2022
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solar lentigo